Apr 10 |
S&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings
|
Apr 10 |
Jaguar Health shareholders approve reverse stock split
|
Apr 9 |
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
|
Apr 8 |
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
|
Apr 3 |
Jaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022)
|
Apr 2 |
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript
|
Apr 2 |
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
|
Apr 2 |
Q4 2023 Jaguar Health Inc Earnings Call
|
Apr 1 |
Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript
|
Apr 1 |
Jaguar Health GAAP EPS of -$1.79, revenue of $9.76M
|